Allogene Therapeutics, Inc. · NASDAQ:ALLO
FMR LLC's stake in Allogene Therapeutics, Inc. fell to 4.90% (Schedule 13G/A)
Event Feb 28, 2025 · Filed Mar 7, 2025
FMR LLC's stake in Allogene Therapeutics, Inc. fell to 4.90%, 10,225,851 shares, as a passive investor on Feb 28, 2025. Filed Mar 7, 2025 (Schedule 13G/A).
- Stake
- 4.90%
- Shares
- 10,225,851
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| FMR LLC | 4.90% | 10,225,851 |
| Abigail P. Johnson | 4.90% | 10,225,851 |
Source
Related
- Allogene Therapeutics, Inc.
- FMR LLC
- Allogene Therapeutics, Inc. shareholders
- Schedule 13G/A · FMR LLC · Feb 12, 2025
- Schedule 13D/A · Tpg Gp A, LLC · Sep 30, 2026
- Form 4 · Douglas Earl Martin · Aug 25, 2026
- Schedule 13G/A · Frazier Life Sciences Public Fund, L.P. · Aug 14, 2026
- Schedule 13G/A · Arie Belldegrun, M.D. · Aug 7, 2026
- Schedule 13G · State Street Corp · Aug 7, 2026